Adaptimmune Therapeutics shares owned by Harbor Capital Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Harbor Capital Advisors
from 13F filings
Historical chart of Harbor Capital Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Harbor Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Harbor Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $117k | 148k | 0.79 |
| 2023-09-30 | $105k | 134k | 0.78 |
| 2023-06-30 | $104k | 113k | 0.93 |